What is EXOZ's return on equity?

EXOZ (EXOZ) reported return on equity of -185.8% in Q1 2026.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

EXOZ EXOZ Return on equity

Return on equity at other companies

GevoGEVO

-7.4%-2.6pp

Ginkgo BioworksDNA

-55.8%-1.8pp

Nature's Sunshine ProductsNATR

11.9%+5.5pp

Opko HealthOPK

-16.9%-21.7pp

UpexiUPXI

-468.5%-935pp

West Pharmaceutical ServicesWST

19.1%+1.7pp

Other financials

Income statement

See full

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

See full

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

See full

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

See full

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

See full

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

See full

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Calculated from EXOZ’s reported figures.

net income/total stockholders equity=-185.8%

Based on trailing twelve months.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EXOZ's return on equity?: EXOZ (EXOZ) reported return on equity of -185.8% in Q1 2026.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.